Application of antioxidants and other agents to prevent cisplatin ototoxicity.
about
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale.Cisplatin ototoxicity and protection: clinical and experimental studiesTRPV1: A Potential Drug Target for Treating Various Diseases.The design and screening of drugs to prevent acquired sensorineural hearing lossFuture approaches for inner ear protection and repair.Age-related hearing loss: is it a preventable condition?The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs.Is intratympanic injection of erdosteine protective against cisplatin-induced ototoxicity?Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem.Protective effects of pine bark extract against cisplatin-induced hepatotoxicity and oxidative stress in ratsBucillamine prevents cisplatin-induced ototoxicity through induction of glutathione and antioxidant genes.Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation.SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastomaUnderstanding drug ototoxicity: molecular insights for prevention and clinical management.Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.A combination of cilostazol and Ginkgo biloba extract protects against cisplatin-induced Cochleo-vestibular dysfunction by inhibiting the mitochondrial apoptotic and ERK pathways.Mechanisms of cisplatin ototoxicity: theoretical review.Protective effect of ursolic acid from Cornus officinalis on the hydrogen peroxide-induced damage of HEI-OC1 auditory cells.Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin.Emerging Therapies for Sensorineural Hearing Loss.Role of antioxidants in prevention of age-related hearing loss: a review of literature.Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract.Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action.Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors.Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats.Efficacy of topotecan treatment on antioxidant enzymes and TBA-RS levels in submandibular glands of rabbits: an experimental study.Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats.Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss.Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.Isosorbide delays gentamicin-induced vestibular sensory cell death.The role of hyperbaric oxygen therapy (hot) as an otoprotection agent against cisplatin ototoxicity.Protective effect of edaravone against tobramycin-induced ototoxicity.Inhibition of Mitochondrial Division Attenuates Cisplatin-Induced Toxicity in the Neuromast Hair Cells.Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.
P2860
Q21146752-7C4E08B8-25B5-43BC-A257-DBCB3B097C79Q24615296-191239F8-6AAC-45BE-8C85-969F25F65575Q24628775-664292F6-447A-47FC-9C71-95BCA7D7B479Q30434994-7E7D69AA-F5DF-47F1-A532-ECDC3611CF80Q30465748-A80AE1BB-6BE1-462B-B981-2B2B43D47273Q30474951-320CEC31-6EAB-4BAA-B24A-93816B964676Q30475283-D6EDD864-EC79-4FE8-9748-B4641F7910B6Q30493005-EC8D7FA6-2AED-4A33-87CA-6A1DE964172CQ34046822-14EA15ED-1451-4446-AC64-CF1FDC62DA3FQ34093169-02579874-44D9-48D7-9220-E2B69506BB9EQ34110153-43CADC4A-457B-42D9-93E5-562440B5F3B7Q34224262-C19F1F83-10E2-40AF-AFB1-D0A746C3A1EFQ35014354-92BFB637-E618-4577-9CE6-CE2D3FC31F73Q35137650-045EED20-B2D4-490E-A58A-325140936763Q35738714-28BDAFCE-74E4-479C-AEDD-0178B588A85CQ36358551-31F2C805-BE19-444F-B9E6-1CCD8B15120EQ36446895-40B7814C-4ED0-403D-9E64-F59623269776Q36881759-15E06A13-F15F-4E0F-A7A4-FC67B3B1CF5DQ37073643-A48DD6AF-06D1-4F78-A681-2FA460F996FCQ38104833-292B0213-8578-422F-BDDE-B7F11C51241CQ38493200-12652893-4579-4057-A3B8-26794B1576F7Q38511160-14FB7ACB-2CB9-4FD3-B0EC-D88AA2406D69Q38850515-D8A23C91-31D8-43F4-B354-675E03390933Q39011706-AE1388B5-86AC-486A-9001-B670ECAA1B05Q39052637-77EEEB28-8C94-4EE7-AE75-784D17A25102Q42361422-841B55F2-1A2C-404E-86D2-7F860BEEDD51Q42485946-96E5B283-F1D8-4493-ACDE-85D6D1BDA234Q43988771-2E73252D-9143-44FB-BC06-BB1CC61936FEQ44242814-9C63FB8D-D514-4A16-83F1-4238131728E8Q44354761-1A45A730-32B5-419D-8880-72C4A81C55D2Q45033400-B8D2935E-B2D4-4E54-8C9D-16BD0962575EQ45212110-7F4ED110-BDC0-47A3-9973-B27FEA2C5D6CQ45816259-7C586231-CC74-4B51-B867-A909BB6F6A7DQ45976669-650D7327-3EED-48DE-B9DB-10926D1852F9Q46256727-A29EB0CD-DD35-429A-A5F3-5CB88E27735BQ46461340-012E7940-3B3B-42B3-B2D1-F1EF6EDAEFC9Q46487208-A5D4B83F-55CC-48B7-B8F8-FCF05D409CA0Q46496616-E255650C-D55B-45B5-B6D0-B2ADEF1AEA9EQ47194882-3BF259DC-8769-41C4-B9AE-02F4A783C34EQ47716828-396A2B79-3882-440C-B73B-45F256408281
P2860
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@ast
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@en
type
label
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@ast
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@en
prefLabel
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@ast
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@en
P2093
P1433
P1476
Application of antioxidants and other agents to prevent cisplatin ototoxicity.
@en
P2093
P2860
P304
P356
10.1097/00005537-199911000-00003
P407
P577
1999-11-01T00:00:00Z